US6689579B1
(en)
|
1996-10-25 |
2004-02-10 |
Human Genome Sciences, Inc. |
Polynucleotides encoding neutrokine-α
|
US6812327B1
(en)
|
1996-10-25 |
2004-11-02 |
Human Genome Sciences, Inc. |
Neutrokine-alpha polypeptides
|
CA2232743A1
(en)
*
|
1997-04-02 |
1998-10-02 |
Smithkline Beecham Corporation |
A tnf homologue, tl5
|
CA2292835A1
(en)
*
|
1997-06-06 |
1998-12-10 |
Regeneron Pharmaceuticals, Inc. |
Ntn-2 member of tnf ligand family
|
AU9376498A
(en)
*
|
1997-09-05 |
1999-03-22 |
University Of Washington |
Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
|
EA200000311A1
(en)
*
|
1997-09-12 |
2000-10-30 |
Апотек Р Энд Д Са |
NEW PROTEIN IMMUNE SYSTEM - KAU
|
JP2002503444A
(en)
*
|
1997-11-26 |
2002-02-05 |
イーライ・リリー・アンド・カンパニー |
Ligand family genes
|
US6297367B1
(en)
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
AU2093499A
(en)
*
|
1997-12-30 |
1999-07-19 |
Chiron Corporation |
Members of tnf and tnfr families
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
GB9828628D0
(en)
*
|
1998-12-23 |
1999-02-17 |
Glaxo Group Ltd |
Novel ligand
|
US7833529B1
(en)
|
1999-01-07 |
2010-11-16 |
Zymogenetics, Inc. |
Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
|
US20030095967A1
(en)
|
1999-01-25 |
2003-05-22 |
Mackay Fabienne |
BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
|
HUP0105283A3
(en)
|
1999-01-25 |
2004-08-30 |
Biogen Idec Ma Inc Cambridge |
Baff, inhibitors thereof and their use in the modulation of b-cell response
|
US6475986B1
(en)
*
|
1999-02-02 |
2002-11-05 |
Research Development Foundation |
Uses of THANK, a TNF homologue that activates apoptosis
|
JP2003526330A
(en)
*
|
1999-02-23 |
2003-09-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
Neutrokine-α and Neutrokine-α splice variants
|
JP2002540791A
(en)
*
|
1999-04-05 |
2002-12-03 |
インサイト・ファーマスーティカルズ・インコーポレイテッド |
Immune system molecules
|
CA2370562A1
(en)
*
|
1999-04-09 |
2000-10-19 |
Human Genome Sciences, Inc. |
49 human secreted proteins
|
US20030022233A1
(en)
*
|
1999-04-30 |
2003-01-30 |
Raymond G. Goodwin |
Methods of use of the taci/taci-l interaction
|
WO2000068378A1
(en)
*
|
1999-05-06 |
2000-11-16 |
National Jewish Medical And Research Center |
Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
|
PL211786B1
(en)
|
1999-08-17 |
2012-06-29 |
Apoxis Sa |
Application of an antibody and a polypeptide
|
UA74798C2
(en)
|
1999-10-06 |
2006-02-15 |
Байоджен Айдек Ма Інк. |
Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors
|
CA2897626C
(en)
|
2000-02-11 |
2020-03-24 |
Biogen Idec Ma Inc. |
Heterologous polypeptide of the tnf family
|
ATE511857T1
(en)
|
2000-02-16 |
2011-06-15 |
Genentech Inc |
ANTI-APRIL MONOCLONAL ANTIBODIES AND THEIR USE IN THE TREATMENT OF IMMUNE DISEASES OR CANCER
|
US20020086018A1
(en)
|
2000-05-12 |
2002-07-04 |
Theill Lars Eyde |
Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI
|
ES2609016T3
(en)
|
2000-06-16 |
2017-04-18 |
Human Genome Sciences, Inc. |
Antibodies that bind immunospecifically to BLyS
|
US7220840B2
(en)
|
2000-06-16 |
2007-05-22 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator protein
|
AU2001288260A1
(en)
*
|
2000-08-15 |
2002-03-13 |
Human Genome Sciences, Inc. |
Neutrokine-alpha and neutrokine-alpha splice variant
|
US20030091565A1
(en)
|
2000-08-18 |
2003-05-15 |
Beltzer James P. |
Binding polypeptides and methods based thereon
|
UA83458C2
(en)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
|
ES2387546T3
(en)
|
2001-05-11 |
2012-09-25 |
Amgen Inc. |
Peptides and related molecules that bind to TALL-1
|
EA007275B1
(en)
|
2001-05-24 |
2006-08-25 |
Займодженетикс, Инк. |
Taci-immunoglobulin fusion proteins
|
AR035119A1
(en)
|
2001-08-16 |
2004-04-14 |
Lilly Co Eli |
ANTI-HTNFSF13B HUMAN ANTI-BODIES
|
AU2004233164B2
(en)
|
2003-03-28 |
2009-10-08 |
Biogen Ma Inc. |
Truncated BAFF receptors
|
KR20060027801A
(en)
|
2003-06-05 |
2006-03-28 |
제넨테크, 인크. |
Combination therapy for b cell disorders
|
EP1709072A1
(en)
*
|
2004-01-29 |
2006-10-11 |
Genentech, Inc. |
Variants of the extracellular domain of bcma and uses thereof
|
BRPI0516297A
(en)
|
2004-10-05 |
2008-09-02 |
Genentech Inc |
Vasculitis treatment methods and articles of manufacture
|
EP2332563A3
(en)
|
2004-10-13 |
2013-03-13 |
The Washington University |
Use of BAFF to treat sepsis
|
WO2006067210A1
(en)
|
2004-12-23 |
2006-06-29 |
Laboratoires Serono S.A. |
Bcma polypeptides and uses thereof
|
AU2006278227B2
(en)
|
2005-08-09 |
2011-10-20 |
Ares Trading S.A. |
Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
|
CA2618765A1
(en)
|
2005-08-09 |
2007-02-15 |
Zymogenetics, Inc. |
Methods for treating b-cell malignancies using taci-ig fusion molecule
|
US9168286B2
(en)
|
2005-10-13 |
2015-10-27 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
AU2006318539B2
(en)
|
2005-11-23 |
2012-09-13 |
Genentech, Inc. |
Methods and compositions related to B cell assays
|
WO2007123765A2
(en)
|
2006-03-31 |
2007-11-01 |
Human Genome Sciences Inc. |
Neutrokine-alpha and neutrokine-alpha splice variant
|
KR20090016707A
(en)
|
2006-05-15 |
2009-02-17 |
아레스 트레이딩 에스.에이. |
Methods for treating autoimmune diseases using a taci-ig fusion molecule
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
CN102597268B
(en)
|
2009-09-03 |
2017-09-22 |
弗·哈夫曼-拉罗切有限公司 |
For treat, diagnose and monitoring rheumatoid arthritis method
|
WO2012118750A2
(en)
|
2011-02-28 |
2012-09-07 |
Genentech, Inc. |
Biological markers and methods for predicting response to b-cell antagonists
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(en)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
Proteins specific for baff and b7rp1 and uses thereof
|